Login
Home / LTUS : OTC
Follow Compare
AI Analysis Fundamentals Valuation Video Analysis Similar
Quarterly Quarterly (TTM) Annually

AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Lotus Pharmaceuticals, Inc.

$0 +$0.00 (+0.00%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$0
Day Range
$0$0
Year Range
$0$0.01
Market Cap
82.31K
AVG Volume
4.28K
Trailing/Forward PE
-263.18/-
PEG ratio
-2.63
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (USD)
00.250.50.75123 Q424 Q124 Q224 Q324 Q425 Q225 Q325 Q426 Q126 Q2
Net Income (USD)
-50K050K100K150K23 Q424 Q124 Q224 Q324 Q425 Q225 Q325 Q426 Q126 Q2
Operating Income (USD)
-15K-10K-5K023 Q424 Q124 Q224 Q324 Q425 Q225 Q325 Q426 Q126 Q2
EBITDA (USD)
-50K050K100K150K23 Q424 Q124 Q224 Q324 Q425 Q225 Q325 Q426 Q126 Q2
Cash Flows (USD)
-40K-30K-20K-10K021 Q422 Q222 Q322 Q423 Q123 Q223 Q323 Q424 Q124 Q2
EPS (USD)
00.250.50.75123 Q424 Q124 Q224 Q324 Q425 Q225 Q325 Q426 Q126 Q2
Expenses (USD)
05K10K15KR&DSG&ACapex23 Q424 Q124 Q224 Q324 Q425 Q225 Q325 Q426 Q126 Q2
Cash & Debt (USD)
050K100K150KCashLong Term DebtShort Term Debt22 Q122 Q222 Q322 Q423 Q123 Q223 Q323 Q424 Q124 Q2
Debt ratios
-10010203011 Q211 Q322 Q322 Q423 Q123 Q223 Q323 Q424 Q124 Q2
Margins
0%20%40%60%09 Q209 Q309 Q410 Q110 Q210 Q310 Q411 Q111 Q211 Q3
Return on Capital
0%5%10%15%22 Q122 Q222 Q322 Q423 Q123 Q223 Q323 Q424 Q124 Q2
Shares Outstanding
01B2B3B23 Q424 Q124 Q224 Q324 Q425 Q225 Q325 Q426 Q126 Q2
Book Value Per Share (USD)
-0-0-0-022 Q122 Q222 Q322 Q423 Q123 Q223 Q323 Q424 Q124 Q2
Total Assets (USD)
02K4K6K22 Q122 Q222 Q322 Q423 Q123 Q223 Q323 Q424 Q124 Q2
PE Ratio
0100200300med 93.65Dec 20Apr 21May 25Aug 25Nov 25Mar 26Jun 26
Free Cash Flow Yield
-600%-400%-200%0%med -0.19%Mar 21Jun 21Oct 23Jan 24May 24Sep 24Dec 24
Price to Sales
00.020.040.060.08med 0.01Oct 19Jan 20May 20Aug 20Nov 20Mar 21Jun 21
EV/EBITDA
025005000750010000med 114.18Mar 21Jun 21Jul 23Oct 23Feb 24Jun 24Sep 24
Price/Operating Cashflow
00.10.20.3med 0.02Oct 19Jan 20May 20Aug 20Nov 20Mar 21Jun 21
Price to Book
00.020.040.06med 0Oct 19Jan 20May 20Aug 20Nov 20Mar 21Jun 21
Lotus Pharmaceuticals, Inc.
LTUS
Stockpicker

Video analysis: LTUS

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.